The Brisbane Times is reporting that at least 1,500 Australians have filed claims for compensation from Merck's Australian subsidiary, related to Vioxx® -- which, it is alleged, elevated cardiovascular risks in arthritis patients who used to take the painkiller (it was withdrawn, worldwide in 2004).
Earlier in August, The Sydney (Australia) Morning Herald had reported that 350 claimants had surfaced.
. . . .A total of 1500 people have come forward claiming they have had a heart attack after taking the anti-arthritis drug Vioxx.
The potential claimants were ordered to register by this week with the law firm Slater & Gordon, or directly with the Federal Court, if they intended to join a class action against Merck Sharp & Dohme (Australia), which sold the drug in Australia. . . .
Ealrier this year, we detailed an able Australian trial judge's finding that Vioxx was a "defective product" under applicable Australian law [with additional updates, here]. As ever, we'll keep you up to speed.
No comments:
Post a Comment